News

Findings from a recent study suggest that the herpes virus can be modified into an effective treatment for some types of advanced melanoma. Conducte ...
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...
The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...
CLDI Stock- Calidi Biotherapeutics raises $4.6M via discounted warrants to fund clinical programs and extend operational ...